Literature DB >> 29952002

Role of immune cells in hypertension.

Antoine Caillon1, Pierre Paradis1, Ernesto L Schiffrin1,2.   

Abstract

Inflammatory processes have been shown to play an important role in the mechanisms involved in the pathogenesis of hypertension. Innate and adaptive immune responses participate in BP elevation and end-organ damage. Here, we discuss recent studies focusing on novel inflammatory and immune mechanisms that play roles in BP elevation. Different subpopulations of cells involved in innate and adaptive immune responses, such as dendritic cells, monocytes/macrophages and NK cells, on the one hand, and B and T lymphocytes, on the other, contribute to the vascular and kidney injury in hypertension. Unconventional innate-like T cells such as γδ T cells also participate in hypertensive mechanisms by priming both innate and adaptive immune cells, contributing to trigger vascular inflammation and BP elevation. These cells exert their effects in part via production of various cytokines including pro-inflammatory IFN-γ and IL-17 and anti-inflammatory IL-10. The present review summarizes some of these immune mechanisms that participate in the pathophysiology of hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2018        PMID: 29952002      PMCID: PMC6534777          DOI: 10.1111/bph.14427

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  83 in total

1.  T regulatory lymphocytes prevent aldosterone-induced vascular injury.

Authors:  Daniel A Kasal; Tlili Barhoumi; Melissa W Li; Naoki Yamamoto; Evguenia Zdanovich; Asia Rehman; Mario F Neves; Pascal Laurant; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2011-12-05       Impact factor: 10.190

2.  Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice.

Authors:  Khalid Matrougui; Zakaria Abd Elmageed; Abd Elmageed Zakaria; Modar Kassan; Sookyoung Choi; Devika Nair; Romer A Gonzalez-Villalobos; Aziz A Chentoufi; Philip Kadowitz; Souad Belmadani; Megan Partyka
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Innate immunity in hypertension.

Authors:  Muhammad Oneeb Rehman Mian; Pierre Paradis; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

4.  Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit.

Authors:  Mauricio Rosas-Ballina; Peder S Olofsson; Mahendar Ochani; Sergio I Valdés-Ferrer; Yaakov A Levine; Colin Reardon; Michael W Tusche; Valentin A Pavlov; Ulf Andersson; Sangeeta Chavan; Tak W Mak; Kevin J Tracey
Journal:  Science       Date:  2011-09-15       Impact factor: 47.728

5.  The angiogenic factor PlGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension.

Authors:  Daniela Carnevale; Fabio Pallante; Valentina Fardella; Stefania Fardella; Roberta Iacobucci; Massimo Federici; Giuseppe Cifelli; Massimiliano De Lucia; Giuseppe Lembo
Journal:  Immunity       Date:  2014-11-07       Impact factor: 31.745

6.  Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients.

Authors:  F Olsen
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-02

7.  Myeloid CD11c+ Antigen-Presenting Cells Ablation Prevents Hypertension in Response to Angiotensin II Plus High-Salt Diet.

Authors:  Daniel Hevia; Patricio Araos; Carolina Prado; Eugenia Fuentes Luppichini; Macarena Rojas; Rodrigo Alzamora; Flavia Cifuentes-Araneda; Alexis A Gonzalez; Cristian A Amador; Rodrigo Pacheco; Luis Michea
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

8.  Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.

Authors:  Congcong Zhang; Yulin Li; Chunxiao Wang; Yina Wu; Wei Cui; Takashi Miwa; Sayaka Sato; Huihua Li; Wen-Chao Song; Jie Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-17       Impact factor: 8.311

9.  DC isoketal-modified proteins activate T cells and promote hypertension.

Authors:  Annet Kirabo; Vanessa Fontana; Ana P C de Faria; Roxana Loperena; Cristi L Galindo; Jing Wu; Alfiya T Bikineyeva; Sergey Dikalov; Liang Xiao; Wei Chen; Mohamed A Saleh; Daniel W Trott; Hana A Itani; Antony Vinh; Venkataraman Amarnath; Kalyani Amarnath; Tomasz J Guzik; Kenneth E Bernstein; Xiao Z Shen; Yu Shyr; Sheau-chiann Chen; Raymond L Mernaugh; Cheryl L Laffer; Fernando Elijovich; Sean S Davies; Heitor Moreno; Meena S Madhur; Jackson Roberts; David G Harrison
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

Review 10.  Differentiation of human innate lymphoid cells (ILCs).

Authors:  Kerstin Juelke; Chiara Romagnani
Journal:  Curr Opin Immunol       Date:  2015-12-17       Impact factor: 7.486

View more
  40 in total

Review 1.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

Review 2.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

3.  Immunity and hypertension: New targets to lighten the pressure.

Authors:  Antony Vinh; Grant R Drummond; Christopher G Sobey
Journal:  Br J Pharmacol       Date:  2019-06       Impact factor: 8.739

Review 4.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

5.  Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.

Authors:  David L Mattson; John Henry Dasinger; Justine M Abais-Battad
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

6.  Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.

Authors:  LouJin Song; Xian Chen; Terri A Swanson; Brianna LaViolette; Jincheng Pang; Teresa Cunio; Michael W Nagle; Shoh Asano; Katherine Hales; Arun Shipstone; Hanna Sobon; Sabra D Al-Harthy; Youngwook Ahn; Steven Kreuser; Andrew Robertson; Casey Ritenour; Frank Voigt; Magalie Boucher; Furong Sun; William C Sessa; Rachel J Roth Flach
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

7.  Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients.

Authors:  Olga Berillo; Ku-Geng Huo; Júlio C Fraulob-Aquino; Chantal Richer; Marie Briet; Pierre Boutouyrie; Mark L Lipman; Daniel Sinnett; Pierre Paradis; Ernesto L Schiffrin
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

8.  Greater T Regulatory Cells in Females Attenuate DOCA-Salt-Induced Increases in Blood Pressure Versus Males.

Authors:  Kasey M Belanger; G Ryan Crislip; Ellen E Gillis; Mahmoud Abdelbary; Jacqueline B Musall; Riyaz Mohamed; Babak Baban; Ahmed Elmarakby; Michael W Brands; Jennifer C Sullivan
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

Review 9.  Sex Differences in Hypertension: Where We Have Been and Where We Are Going.

Authors:  Lindsey A Ramirez; Jennifer C Sullivan
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

10.  Ambulatory blood pressure in patients with systemic lupus erythematosus: Association with markers of immune activation.

Authors:  Daniel A Carranza-Leon; Annette Oeser; Qiong Wu; C Michael Stein; Michelle J Ormseth; Cecilia P Chung
Journal:  Lupus       Date:  2020-08-25       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.